Hereditary Pulmonary
Risk Evaluation
Identify Genetic Risk Before Symptoms Progress.
Coverage
>96% at 20x
Sample Type
Buccal / Saliva
Advanced Next-Generation Sequencing helps identify genetic variants associated with inherited lung disorders, empowering earlier diagnosis and personalized care planning.
Why Genetic Pulmonary
Testing Matters
Many pulmonary diseases have inherited genetic components that traditional clinical evaluations may overlook.
Genetic testing provides deeper insight into hereditary disease risk, disease progression, targeted intervention opportunities, and personalized treatment strategies.
Diagnostic Precision
Confirm clinical diagnoses with precise gene identifications.
Targeted Care
Formulate proactive healthcare plans before symptoms escalate.
Risk Prevention
Better diagnostic tracking and screening opportunities.
Family Protection
Identify family screening opportunities for close relatives.
Hereditary Pulmonary Conditions Assessed
Advanced genomic insights into a broad spectrum of inherited respiratory disorders.
Alpha-1 Antitrypsin Deficiency
PrimaryPrimary Ciliary Dyskinesia (PCD)
Interstitial Lung Disease (ILD)
Pulmonary Fibrosis
Cystic Fibrosis
PrimaryPulmonary Alveolar Proteinosis
Surfactant Protein Disorders
LAM (Rare Pulmonary Disease)
Comprehensive 68-Gene Risk Panel
Advanced genomic sequencing across clinically relevant pulmonary genes for hereditary disease risk evaluation.
...and 36 other genes. Search specifically to filter.
How Pulmonary Genetic Testing Works
Genetic Counseling
Clinical consultation helps determine testing suitability.
Sample Collection
Simple saliva or buccal swab collection.
DNA Sequencing & Analysis
Advanced genomic processing identifies clinically relevant variants.
Clinical Interpretation
Likely pathogenic and pathogenic variants reported to providers.
What Happens After a Positive Finding?
A proactive approach to lung health begins with clear, actionable insights derived from genomic data.
Risk Assessment
Evaluate hereditary pulmonary risk.
Personalized Treatment Plan
Targeted care planning.
Specialist Referral
Pulmonologists & genetic experts.
Family Screening
Risk evaluation for relatives.
Long-Term Monitoring
Disease progression tracking.
Why Consider Genetic Testing?
Diagnose Disease Earlier
Personalized Treatment
Family Planning Insights
Risk Reduction Strategies
Test Specifications
Sample Type
Buccal Swab / Saliva
Turnaround Time
7–10 Business Days
Coverage
>96% at 20x
Reporting
Pathogenic Variants
Customization
Custom Gene Lists Available
Built for Precision
Clinical Workflows.
Integrate advanced genomic testing seamlessly into your practice with our dedicated provider solutions designed to save time.
- Provider ordering portal
- Secure genomic reporting
- Personalized clinical interpretation
- Family screening guidance
- Specialist referral support
Patient Name
Sarah Jenkins
Ordered Panel
Pulmonary NGS Panel (68 Genes)
Variants Identified
Pathogenic - Associated with Cystic Fibrosis
Alpha-1 Antitrypsin deficiency risk
Understanding Genetic
Pulmonary Testing
Take a Deeper Look at
Pulmonary Health.
Empower earlier detection and personalized hereditary pulmonary care through advanced genomic sequencing.